Breathebeat

Slow-breathing practice that shows your heart settling, sold through employers

Employers Wearables

TL;DR Breathebeat is a phone app that walks you through five to ten minutes of slow breathing. It reads your heart rhythm from a smartwatch, a chest strap or the phone camera and shows you, live, when your body starts to calm down. Employers buy it as a stress benefit. It is a wellness tool, not therapy.

The problem

India's National Mental Health Survey found that 10.6% of adults had a current mental disorder. It also found that 85% of people with common conditions like anxiety and depression got no treatment, and that the rates were higher in big cities[1]. Most stressed workers aren't ill though. They're tense, sleeping badly and always short on time.

Plenty of apps play calming audio, but you can't see whether anything changed in your body and so the habit is easy to drop after a week. What about employers? Stress management is the fastest-growing part of India's corporate wellness spend[2], yet most of what they buy is talks and helplines.

The idea

What it does, in regulatory terms - general wellness only. It does not diagnose, treat or monitor any disorder. CDSCO's 2026 software guidance keeps general wellness apps out of the medical-device rules[3], and Breathebeat stays there by making no claims about anxiety disorders, hypertension or any other condition.

A session opens with two minutes to find your comfortable slow pace, usually near six breaths a minute. A visual guide then sets the rhythm while the app tracks heart-rate variability, so you actually watch your rhythm smooth out. Short cyclic-sigh drills cover the tense moments in the day. Everything comes in Hindi, English and three regional languages.

The seed pitched this as breathwork therapy for chronic stress. I reframed it as wellness training because the evidence backs a stress-reduction claim and not a treatment claim. A meta-analysis of 24 studies found large drops in self-reported stress with heart-rate-variability biofeedback, and its authors still asked for better-controlled trials[4]. A separate review of 12 trials of plain breathwork found a smaller effect[5].

Who pays

The user is a salaried professional aged 25–45. The payer is the employer's HR or benefits team, out of a wellness budget or a health-insurance add-on. Consumer prices give you a ceiling - the paid tier of one popular breathing app costs US$9 a month (about ₹870)[6]. My rough estimate is ₹40–80 per employee per month, with a minimum contract of 500 seats.

Why now

CDSCO's final guidance on medical software, out in July 2026, draws the wellness line clearly for the first time[3]. Phone cameras and a lot of smartwatches can already read pulse, so employers don't have to buy any device. The evidence keeps piling up too. A 2023 randomised trial found that five minutes a day of cyclic sighing lifted mood more than mindfulness meditation over a month[7].

Market signal

There's no public figure for breathing or biofeedback apps in India. The adjacent number - one market research firm puts India's corporate wellness market at US$664.5 million in 2025 (about ₹6,400 Cr), with stress management the fastest-growing segment[2].

One Indian online yoga platform says it has over 2 crore members for online yoga and breathing classes[8], which tells you Indians will practise daily when a session is short and guided.

Who's already doing this

That yoga platform is the closest Indian habit product, but it runs live classes with no biofeedback[8]. A US breathing app, now owned by a fitness-equipment company, has more than 50 guided exercises and no sensor loop[6]. A global heart-rate tracking app reads heart-rate variability against a personal baseline and claims 17 million downloads[9], but it's a tracking app and not a breathing coach.

The gap is a short, Indian-language practice that closes the loop with your own heart data and sells to employers.

How hard is it?

Difficulty Moderate (39/100)
Starting capital ₹77 L–1.35 Cr
Time to launch 6–9 months

The tricky engineering is getting reliable heart-rate variability out of cheap phone cameras and many smartwatch brands. The harder problem is engagement. Corporate wellness apps often get a burst of sign-ups and then silence, so your renewals depend on proving that people keep practising.

Licences and approvals

No licence is needed while it stays a general wellness app, and keeping it that way is the whole game.

  • CDSCO software scope check. CDSCO's July 2026 guidance places general wellness apps outside device rules, but software that targets a condition is classed A–D[3]. Get a regulatory adviser to review every claim before launch.
  • Medical Devices Rules 2017 apply in full if you later make a clinical claim, so treat that as a separate product[10].
  • DPDP Act compliance before the first session, because heart-rate data is personal data. Each employee consents, and employers see only aggregates[11].
  • CCPA misleading-ad guidelines. Research claims must name their source and date[12].

Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.

How AI can power this business

  • Camera pulse reading. Computer vision can estimate heart rate from the phone camera, so people without a wearable can still see their rhythm.
  • Pace finding. The app learns each person's comfortable slow breathing rate from the first sessions and sets the guide to it.
  • Nudges. Usage patterns can suggest the best time of day to prompt someone, which helps keep weekly practice going.
  • HR reports. AI summarises anonymous usage trends for the employer without exposing anyone's readings.

Don't trust AI to judge anyone's mental health. Breathebeat is wellness training, so it shouldn't flag anxiety or blood pressure, and camera readings need checking against a chest strap before you rely on them.

Want to work out the AI layer for Breathebeat? Talk to Yash →

Biggest risks

Here's what can go south -

  • Engagement drop-off. If weekly use falls below a fifth of seats then HR will not renew.
  • Claim drift. A sales deck that promises to cure anxiety would push the product into medical-device territory.
  • Signal quality. Noisy camera readings could show users false calm or false stress, which kills the whole point.

Our take

I like this one for a founder with health-sensor or consumer-app experience who's happy to sell to HR teams patiently. If you want to call it therapy then it isn't for you. Prove two numbers first - camera readings that track a chest strap closely, and 30% of employees in a pilot still practising weekly at week six.

Questions founders ask

My estimate is ₹77 L–1.35 Cr, covering the app, camera heart-rate work, content in several languages and HR sales. The kit breaks it down.

Do I need a licence to launch a breathing biofeedback app in India?

Not while it stays general wellness. Once you claim to treat anxiety or blood pressure, CDSCO's device rules apply.

Can I start a breathing biofeedback app in another country?

Yes, the app travels easily. Wellness and medical-device lines are drawn differently abroad, so check your regulator before you write any claim.

Download the kit

The free Breathebeat validation kit has the line-by-line capital breakdown, the effort scoring, the wellness-claims and data-protection checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for HR buyers and employees, and 5 assumptions to test. Download the kit →

Talk to Yash

Thinking about building Breathebeat or something close to it? The make-or-break work is accurate readings on cheap phones and usage that holds past the first month, and that's the kind of thing I help founders with. If you need a hand, you know where to find me. Talk to Yash →

Sources

  1. Murthy, "National Mental Health Survey of India 2015–2016", Indian Journal of Psychiatry 59(1), 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5419008/
  2. Grand View Research, "India Corporate Wellness Market", accessed 2026-10-17. https://www.grandviewresearch.com/horizon/outlook/corporate-wellness-market/india
  3. Emergo by UL, "India CDSCO finalizes guidance on medical device software", 2026-07-30. https://www.emergobyul.com/news/india-cdsco-finalizes-guidance-medical-device-software
  4. Goessl, Curtiss & Hofmann, "The effect of heart rate variability biofeedback training on stress and anxiety: a meta-analysis", Psychological Medicine, 2017 (Europe PMC record). https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28478782%20AND%20SRC:MED&resultType=core&format=json
  5. Fincham et al., "Effect of breathwork on stress and mental health: a meta-analysis of randomised-controlled trials", Scientific Reports 13, 2023-01. https://pmc.ncbi.nlm.nih.gov/articles/PMC9828383/
  6. Breathwrk, official site, accessed 2026-10-17. https://www.breathwrk.com/
  7. Balban et al., "Brief structured respiration practices enhance mood and reduce physiological arousal", Cell Reports Medicine 4(1), 2023-01. https://pmc.ncbi.nlm.nih.gov/articles/PMC9873947/
  8. Habuild, official site, accessed 2026-10-17. https://habuild.in/
  9. Welltory, official site, accessed 2026-10-17. https://welltory.com/
  10. CDSCO, "Medical Device & Diagnostics", accessed 2026-10-17. https://cdsco.gov.in/opencms/opencms/en/Medical-Device-Diagnostics/Medical-Device-Diagnostics/
  11. PRS Legislative Research, "Digital Personal Data Protection Bill 2023", 2023-08. https://prsindia.org/billtrack/digital-personal-data-protection-bill-2023
  12. CAG, "CCPA's guidelines on prevention of misleading advertisements and endorsements", 2022-10. https://www.cag.org.in/newsletters/public-newsense/ccpas-guidelines-prevention-misleading-advertisements-and-endorsements

For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.

Reviews

No reviews yet